SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.310
+0.050 (1.53%)
Mar 31, 2025, 2:34 PM EDT - Market open
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $221.21 million as of March 31, 2025. Its market cap has decreased by -25.22% in one year.
Market Cap
221.21M
Enterprise Value
170.01M
1-Year Change
-25.22%
Ranking
Category
Stock Price
$3.31
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $221.21M, a decrease of -80.25%. That is a compound annual growth rate of -35.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 217.87M | 6.82% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |